ProShares Ultra Nasdaq Biotechnology (BIB)

BATS BZX Real-Time Price
As of 3:30pm ET
 +6.56 / +4.20%
Today’s Change
Today|||52-Week Range
BIB Regular Dividend: BIB began trading ex-dividend on 03/25/15. A $0.00 dividend will be paid to shareholders of record as of 03/27/15.

Investment Objective

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index ®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.


1 month+12.43% 3 years+93.89%
3 months+39.27% 5 years--
1 year+107.81% Since inception+63.25%
Data through 03/25/2015

Quote Details

Previous close$156.21
Open day’s range157.01 – 163.95
Net asset value (NAV)170.57 (03/24/2015)
Daily volume671,303
Average volume (3 months)385,895
Data as of 3:30pm ET, 03/27/2015

Peer Comparisonvs. Trading-leveraged equity ETFs

Performance 5-yr return--+21.46%
Expense Gross exp ratio1.08%0.89%
Risk 5 year sharpe ratio--0.81
Net assets$668.4M$202.5M
Average market cap----
Average P/E----
Dividend / Share--0.20%


SFLA iPath® Long Extended S&P 500® TR Index...
ROLA iPath® Long Extended Russell 1000® TR ...
SSO ProShares Ultra S&P500


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
-- 39.68%
-- 23.26%
-- 18.69%
-- 14.55%
-- 11.66%
-- 10.57%
BIIB Biogen6.27%
CELG Celgene5.59%
AMGN Amgen5.47%
GILD Gilead Sciences5.34%

To view my watchlist

Not a member yet?

Sign up now for a free account